申请人:INDIVIOR UK LIMITED
公开号:US10584135B2
公开(公告)日:2020-03-10
The disclosure provides compounds having formula (I), where the substituents are as defined herein.
The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.
本公开提供了具有式 (I) 的化合物,其中的取代基如本文所定义。
这些化合物可用于调节多巴胺 D3 受体和治疗与之相关的疾病,如成瘾、药物依赖和精神疾病。